Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023
   Working Capital/Sales(x) 0.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 0.79 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹112.4 Cr 3.1% NA -10.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹11,473.1 Cr 1.4% 15.8% 47.7% Stock Analytics
KIRI INDUSTRIES ₹3,193.2 Cr -0.7% -8.8% 52.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,853.5 Cr -1.3% -9.1% -13.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,134.6 Cr -12.7% -3.4% 48.1% Stock Analytics
BODAL CHEMICALS ₹858.9 Cr -1.6% -11% -12.2% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

3.1%

NA

-10.6%

SENSEX

1.3%

-0.8%

3.2%


You may also like the below Video Courses